Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comprehensive surgical staging for endometrial cancer.

Literature DB >> 22582124

Comprehensive surgical staging for endometrial cancer.

Abstract

Despite a shift from clinical to surgical staging of endometrial cancer in 1988, performance of comprehensive surgical staging for clinically early-stage endometrial cancer remains controversial. Low-, intermediate-, and high-risk groups have been defined pathologically. Herein, we describe the risks and benefits of comprehensive surgical staging. Comprehensive surgical staging is encouraged in high-risk histologies, whereas a method of triage should be used to determine who among the low-grade endometrioid histology may benefit from comprehensive staging.

Entities: Disease

Keywords: Endometrial cancer; Para-aortic lymphadenectomy; Pelvic lymphadenectomy; Surgical staging

Year: 2012 PMID： 22582124 PMCID： PMC3349921

Source DB: PubMed Journal: Rev Obstet Gynecol ISSN： 1941-2797

34 in total

1. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?

Authors: A Mariani; M J Webb; G L Keeney; M G Haddock; G Calori; K C Podratz
Journal: Am J Obstet Gynecol Date: 2000-06 Impact factor: 8.661

2. Cancer statistics, 2010.

Authors: Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal: CA Cancer J Clin Date: 2010-07-07 Impact factor: 508.702

3. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.

Authors: Janiel M Cragun; Laura J Havrilesky; Brian Calingaert; Ingrid Synan; Angeles Alvarez Secord; John T Soper; Daniel L Clarke-Pearson; Andrew Berchuck
Journal: J Clin Oncol Date: 2005-02-28 Impact factor: 44.544

4. A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer.

Authors: Ashley S Case; Rodney P Rocconi; J Michael Straughn; Michael Conner; Lea Novak; Wenquan Wang; Warner K Huh
Journal: Obstet Gynecol Date: 2006-12 Impact factor: 7.661

5. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study.

Authors: R C Boronow; C P Morrow; W T Creasman; P J Disaia; S G Silverberg; A Miller; J A Blessing
Journal: Obstet Gynecol Date: 1984-06 Impact factor: 7.661

6. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

Authors: Pierluigi Benedetti Panici; Stefano Basile; Francesco Maneschi; Andrea Alberto Lissoni; Mauro Signorelli; Giovanni Scambia; Roberto Angioli; Saverio Tateo; Giorgia Mangili; Dionyssios Katsaros; Gaetano Garozzo; Elio Campagnutta; Nicoletta Donadello; Stefano Greggi; Mauro Melpignano; Francesco Raspagliesi; Nicola Ragni; Gennaro Cormio; Roberto Grassi; Massimo Franchi; Diana Giannarelli; Roldano Fossati; Valter Torri; Mariangela Amoroso; Clara Crocè; Costantino Mangioni
Journal: J Natl Cancer Inst Date: 2008-11-25 Impact factor: 13.506

Review 7. The role of adjuvant radiation in endometrial cancer.

Authors: Virginia Diavolitsis; John Boyle; Diljeet K Singh; William Small
Journal: Oncology (Williston Park) Date: 2009-04-15 Impact factor: 2.990

8. Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma.

Authors: T O Wilson; K C Podratz; T A Gaffey; G D Malkasian; P C O'Brien; J M Naessens
Journal: Am J Obstet Gynecol Date: 1990-02 Impact factor: 8.661

9. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.

Authors: Andrea Mariani; Sean C Dowdy; William A Cliby; Bobbie S Gostout; Monica B Jones; Timothy O Wilson; Karl C Podratz
Journal: Gynecol Oncol Date: 2008-03-04 Impact factor: 5.482

10. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Authors: H Kitchener; A M C Swart; Q Qian; C Amos; M K B Parmar
Journal: Lancet Date: 2008-12-16 Impact factor: 79.321

12 in total

1. Association of Lymph Node Count and Overall Survival in Node-Negative Endometrial Cancers.

Authors: Brandon-Luke L Seagle; Douglas Gilchrist-Scott; Stephen Graves; Anna E Strohl; Wilberto Nieves-Neira; Shohreh Shahabi
Journal: JCO Clin Cancer Inform Date: 2017-08-08

2. Sentinel Lymph Node Biopsy in Endometrial Cancer: Dual Injection, Dual Tracer-A Multidisciplinary Exhaustive Approach to Nodal Staging.

Authors: Anna Torrent; Joana Amengual; Catalina Maria Sampol; Mario Ruiz; Jorge Rioja; Gabriel Matheu; Pilar Roca; Octavi Cordoba
Journal: Cancers (Basel) Date: 2022-02-13 Impact factor: 6.639

Review 3. Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations.

Authors: Robert W Holloway; Nadeem R Abu-Rustum; Floor J Backes; John F Boggess; Walter H Gotlieb; W Jeffrey Lowery; Emma C Rossi; Edward J Tanner; Rebecca J Wolsky
Journal: Gynecol Oncol Date: 2017-05-28 Impact factor: 5.482

4. Estimated intermediate risk endometrial cancer: debate and new perspectives on therapy individualization and prognosis establishment starting from a peculiar case.

Authors: Salvatore Gizzo; Alberta Fabris; Pietro Litta; Carlo Saccardi
Journal: Int J Clin Exp Pathol Date: 2014-04-15

5. Pattern of Lymph Node Metastasis in Endometrial Cancer: a Single Institution Experience.

Authors: S Suchetha; Arun Peter Mathew; P Rema; Shaji Thomas
Journal: Indian J Surg Oncol Date: 2020-09-28

6. Evaluation of Survival, Recurrence Patterns and Adjuvant Therapy in Surgically Staged High-Grade Endometrial Cancer with Retroperitoneal Metastases.

Authors: Jennifer McEachron; Lila Marshall; Nancy Zhou; Van Tran; Margaux J Kanis; Constantine Gorelick; Yi-Chun Lee
Journal: Cancers (Basel) Date: 2021-04-23 Impact factor: 6.639

7. Application of Single-Hole Laparoscopy and Sentinel Lymph Node Imaging in Early Endometrial Carcinoma in Special Population.

Authors: Jianqing Zhou; Weili Zhu; Tao Zhu; Xuedong Tang
Journal: Comput Math Methods Med Date: 2021-09-28 Impact factor: 2.238